Tissue Processing Systems Market Size, Share, and Industry Analysis, By Product (Equipment {Fully Automated, Semi-Automated, and Manual}, and Accessories and Consumables), By Type (Tissue Transfer and Fluid Transfer), By Technology (Vacuum-Based, Microwave-Based, and Others), By End User (Hospitals and Clinics, Clinical Laboratories, Research and Academic Institutes, and Others), and Regional Forecast, 2025-2032

The global tissue processing systems market is rapidly growing globally due to an increased demand for laboratory procedures and tissue sample examinations, particularly for medical diagnosis and research purposes. Along with this, the increasing number of laboratories have resulted in the adoption of tissue processors. Tissue processing systems are laboratory instruments that prepare tissue samples for research, pathology diagnosis, and education.

• According to Laboratory of Florida LLC., more than 200,000 clinical laboratories provide testing services in the U.S. in 2022.

Tissue Processing Systems Market Driver

Increasing Number of Biopsies to Drive the Adoption of Tissue Processing Systems among Healthcare Facilities

The rising prevalence of various chronic conditions such as cancer, tuberculosis, kidney disorders, cardiovascular disorders, and others among the general population is leading to a growing diagnosis rate of these conditions. This further is resulting into an increasing number of biopsies conducted among  healthcare facilities to provide accurate diagnosis.

• According to NIH, in 2023, histopathological examination was suggestive of tuberculosis in 83.3% of biopsy specimens.

Request a Free sample to learn more about this report.

According to the Centers for Disease Control and Prevention (CDC), in 2023, the 50 U.S. states and DC provisionally reported 9,615 tuberculosis cases, an increase of 1,295 cases i.e. 16%, compared to the 8,320 cases reported in 2022.

Tissue Processing Systems Market Restraint

High Costs Associated with Tissue Processors May Hinder Market Growth

The limited healthcare resources in emerging countries such as the African countries, Southeast Asian countries, among others, along with the high cost associated with tissue processing systems, are some of the prominent factors expected to hamper the product adoption.

• According to Scientific Laboratory Supplies Ltd., the average cost of an Epredia STP 120 tissue processor is around USD 34,000.

Tissue Processing Systems Market Opportunity

Strategic Mergers and Acquisitions to Provide Opportunities for Growth

The growing focus of key companies toward strategic mergers and acquisitions to develop and introduce innovative devices and solutions with advanced technical features presents a lucrative opportunity for growth in terms of the demand and adoption of tissue processing systems in the market.

• In January 2023, PHC Holdings Corporation partnered with Aiforia, one of the medical software providers, with an aim to expand its brand presence in the advanced tissue processing solutions in the market. 

Segmentation

Key Insights

The report covers the following key insights:

• Prevalence of Key Disorders, By Key Countries, 2023


• Overview: Technological Advancements in Tissue Processing Systems


• Key Industry Developments (Mergers, Acquisitions, Partnerships)


• New Products Launches, By Key Players


• Impact of COVID-19 on the Market

Analysis by Product

By product, the market is segmented into equipment and accessories and consumables.

The equipment segment accounted for a significant market share in 2023. The rising demand and adoption of tissue processors in the developed and emerging countries owing to their technological features and benefits in the diagnosis of various chronic conditions are driving the growth of the segment. The increasing number of hospitals in various countries is another major factor contributing to the segment growth. 

• According to 2022 statistics published by the American Hospital Association (AHA), there were around 6,129 hospitals in the U.S., compared to 6,093 in 2021.

Analysis by Type

Among type, the market is fragmented into tissue transfer and fluid transfer.

The tissue transfer segment accounted for a major market share in 2023. The rising adoption of tissue transfer processors among healthcare facilities, especially with limited resources and space owing to their compact size and efficiency, is one of the vital factors favoring the segment growth. Along with this, the rising focus of key companies introducing tissue transfer models is expected to fuel their adoption in the market.

• In October 2020, Sakura Finetek Japan Co., Ltd. launched Tissue-Tek SmartConnect, a tissue transfer system, with the aim of expanding its product portfolio in the market.

Analysis by Technology

Based on technology, the market is divided into vacuum-based, microwave-based, and others.

The vacuum-based segment accounted for a substantial share of the market in 2023. These processors are a cost-efficient and user-friendly alternative for fast biopsy processing. They are designed for high throughput histology and research purposes, leading to a higher demand for vacuum tissue processors in the tissue processing systems market. The growing adoption of this technology among various healthcare facilities, including research institutes, is expected to drive the segment growth.

• In April 2023, the University of North Texas Health Science Center at Fort Worth, enhanced its tissue processing capabilities by acquiring the Tissue-Tek VIP 6 AI Vacuum Infiltration Processor.

Analysis by End User

Based on end user, the market is fragmented into hospitals and clinics, clinical laboratories, research and academic institutes, and others.

The increasing diagnosis rate among patients suffering from various chronic conditions in hospitals is leading to an increased demand for the processing of tissues and samples for accurate diagnosis and treatment regimes. The increasing healthcare infrastructure in hospitals is further supporting the adoption of these systems in healthcare facilities. 

• According to NIH, in 2020, kidney biopsies were 43.4 per one million person per year and 242.3 biopsies per year.

Regional Analysis

By region, the market has been studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

To gain extensive insights into the market, Request for Customization

North America is a leading region in the market for tissue processing systems, with many key players focusing on developing and introducing novel products with the latest technology. The developed healthcare infrastructure, along with the rising diagnosis rate among healthcare facilities for various chronic conditions, are some of the major factors favoring the growth of the region in the market.

• In 2022, Leica Biosystems expanded its dual-retort tissue processor portfolio in North America with HistoCore PEGASUS.

The rising focus of key players to expand its geographical presence to several European countries to cater to the rising demand for tissue processing systems is one of the prominent factors expected to fuel the market growth in the region.

• In 2023, Bio-Optica Milano S.p.A. launched B-PRO450, a fully programmable, closed-loop, automatic histology processor suitable for processing histological samples.

Asia Pacific has a growing diagnosis rate for many chronic conditions requiring biopsies, resulting in a rising demand for tissue processors. The growing number of product approvals and launches in the region is another factor driving the segment growth.

Key Players Covered

The global tissue processing systems market is fragmented, with a large number of companies with a wide range of product portfolios. The growing focus on developing and introducing systems with technologically advanced features is contributing to the growing market shares of these companies.

The report includes the profiles of the following key players:

• Thermo Fisher Scientific Inc. (U.S.)


• PHC Holdings Corporation (Japan)


• Leica Biosystems Nussloch GmbH (Germany)


• Cardinal Health (U.S.)


• Sakura Finetek Japan Co., Ltd. (Japan)


• Labotronics (U.S.)


• BIOBASE GROUP (China)


• SLEE medical GmbH (Germany)


• Amos Scientific PTY. LTD. (Australia)

Key Industry Developments

• In April 2024, Clarapath, a medical robotics company, entered into a strategic collaboration with Mayo Clinic. The collaboration is aimed at combining Clarapath’s innovative tissue processing solutions and modernizing the laboratory solutions of the clinics.


• In March 2023, BioStem Technologies entered into a definitive agreement to acquire Auxocell Laboratories, Inc., one of the leading solid tissue processing equipment manufacturers, with an aim to expand its product portfolio.